Décompensation aigue des bronchopneumopathies chroniques obstructives et antibiothérapie : Intérêt de la procalcitonine

dc.contributor.advisorBoukhira A.
dc.contributor.authorHalmaoui Aicha
dc.date.accessioned2023-09-19T14:06:51Z
dc.date.accessioned2026-01-28T12:16:41Z
dc.date.available2023-09-19T14:06:51Z
dc.date.issued2019
dc.description.collaboratorSeddiki R.
dc.description.collaboratorBouchentouf R.
dc.description.collaboratorBenjelloun Harzimi A.
dc.description.collaboratorSerghini I.
dc.identifier.urihttps://toubkal.imist.ma/handle/123456789/21345
dc.identifier.urihttps://doi.org/10.83129/toubkal-2810
dc.language.isofr
dc.publisherFaculté de Médecine et de Pharmacie, Marrakechfr_FR
dc.publisherSciences médicalesfr_FR
dc.subject.otherPneumo-phtisiologie
dc.subject.specificBPCO
dc.subject.specificinfection bactérienne
dc.subject.specificinfection virale
dc.subject.specificprocalcitonine
dc.subject.specificantibiothérapie
dc.titleDécompensation aigue des bronchopneumopathies chroniques obstructives et antibiothérapie : Intérêt de la procalcitoninefr_FR

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
these91-19.pdf
Size:
2.2 MB
Format:
Adobe Portable Document Format